Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibody Test in UAE | 550 AED | DHA Licensed Facility DHA Licensed

Executive Summary & Core Metrics

Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited chemiluminescent methodology.

Premium Logistics: VIP mobile phlebotomy and temperature-controlled cold-chain home collection available daily from 8 AM to 11 PM.

Clinical Guidance: Post-test telephonic consultation for result interpretation and next-step recommendations.

Insurance: Direct billing verification via WhatsApp +971 54 548 8731

Corporate Oversight: DNA Labs UAE | DHA Facility License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

Test Overview & Methodology

The Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibody Test is a gold-standard serological biomarker for early rheumatoid arthritis diagnosis, delivering greater than 98% specific detection of autoantibodies targeting citrullinated proteins. This assay is routinely ordered by rheumatologists for early RA identification, orthopaedic specialists for joint evaluation, and internal medicine physicians for autoimmune screening panels.

Comparative Methodology Analysis

Feature	Anti-CCP (CMIA)	Rheumatoid Factor (RF)
Specificity	Greater than 98%; minimal false positives in healthy individuals	Approximately 80-85%; frequently elevated in non-RA conditions
Analytical Method	Chemiluminescent Microparticle Immunoassay (CMIA)	Latex agglutination or nephelometry
Turnaround Time	Results within 24 hours (daily reporting)	24-48 hours
Clinical Utility	Early RA diagnosis, prognostic indicator for erosive disease	General screening marker; lower accuracy in early disease
Price (AED)	550 AED	Approximately 200 AED

Physician Insight & Safety Protocols

“Persistent joint stiffness and discomfort can be distressing for patients. The Anti-CCP test provides a highly specific marker that, when combined with clinical evaluation, enables early intervention to reduce long-term joint damage. I always remind my patients that laboratory findings must be interpreted within the full clinical context and should never replace a consultation.”

— Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132

🔴 Important Safety Advisory

Do not modify or discontinue any prescribed medications without prior discussion with your treating physician. This test is intended to aid diagnosis and should not be used as a sole basis for treatment decisions.

Safety Exclusion Criteria & Emergency Red Flags

This test is not intended for screening asymptomatic individuals without clinical suspicion of inflammatory arthritis.
A negative Anti-CCP result does not exclude rheumatoid arthritis, as seronegative variants exist and require rheumatologic correlation.
Seek immediate medical attention if you develop acute joint swelling with redness, fever, or inability to bear weight on affected limbs.

Patient FAQ & Clinical Guidance

1. What is the Anti-CCP test used for?

The Anti-CCP test detects specific autoantibodies that serve as an early and highly specific marker for rheumatoid arthritis. A positive result supports a diagnosis of RA and may indicate a higher risk for more aggressive, erosive joint disease. This test is not a standalone diagnostic tool and must be interpreted alongside clinical findings and imaging studies.

2. How should I prepare for the Anti-CCP blood test?

No special preparation is required. You may eat and drink normally prior to sample collection. Fasting is not necessary for this serological assay. Our VIP mobile phlebotomy team can collect the sample at your home between 8 AM and 11 PM using a temperature-controlled cold-chain protocol to ensure specimen integrity.

3. When will I receive my Anti-CCP results and how are they interpreted?

Results are typically reported within 24 hours of sample collection. A certified clinician from DNA Labs UAE will provide telephonic guidance to help you understand the numerical value, reference range, and clinical implications of your result. If further rheumatologic evaluation is needed, we will advise accordingly.

UAE Regulatory & Data Privacy Adherence

Compliance with UAE Health Data Protection Frameworks

DNA Labs UAE operates under the jurisdiction of the Dubai Health Authority (DHA) Facility License No. 1143 and fully complies with:

Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) — governing the collection, processing, and storage of personal health information.
Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields — regulating electronic health records and telemedicine data security.
Federal Decree-Law No. 4 of 2016 on Medical Liability — ensuring informed patient consent and clinical safety standards throughout the diagnostic pathway.

All laboratory processes are ISO 9001:2015 certified (Cert. No. INT/EGQ/2509DA/3139), and patient data is encrypted and access-restricted to authorised clinical personnel only.

Clinical & Logistical Metadata

Test Name	Anti-Cyclic Citrullinated Peptide (Anti-CCP) Antibody Test
Price (AED)	550 AED
Turnaround Time	24 hours (daily reporting)
Sample Type / Matrix	Serum (2 mL from 1 SST tube with minimum 1 mL required)
Methodology Used	Chemiluminescent Microparticle Immunoassay (CMIA)
ICD-10-CM Code	M05.8, M06.8, M06.9
LOINC Code	33935-0
DHA Facility License & Laboratory Address	DHA License No. 1143 \| Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE